In Depth: Performance Comparison of OncoBEAM™ RAS CRC and Idylla™ ctKRAS Liquid Biopsy Testing for KRAS Mutation Detection Presented at ASCO GI 2018

HAMBURG, Germany, January 22, 2018 /PRNewswire/ -- Sysmex Inostics, a global leader in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today highlights results presented at the American Society of Clinical Oncology's Gastrointestinal Cancer...

from PR Newswire: //http://ift.tt/2mZCcPg